NCT05980936

Brief Summary

Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences. Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 15, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2025

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2025

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

1.3 years

First QC Date

July 20, 2023

Last Update Submit

February 23, 2025

Conditions

Keywords

Obstructive sleep apneaSymptomatologyMiddle East

Outcome Measures

Primary Outcomes (1)

  • Number of Participants who are found to have obstructive sleep apnea

    Those who are found to have symptoms of OSA will be referred for further evaluation to get the final diagnosis of OSA

    From date of study enrollment until the date of first documented diagnosis of obstructive sleep apnea, assessed up to 4 weeks.

Interventions

Patient will be interviewed and asked of there are symptoms of snoring, day somnolence, chocking or gasping during sleep

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients without known OSA who are admitted to the general medical ward will be Screened for signs and symptoms of OSA by answering the questions that have the statement :Do you have...?". The symptoms include snoring, day time somnolesce, sudden chocking or gasping during sleep..

You may qualify if:

  • Willing to sign an informed consent
  • Patient is admitted to the medical ward in a tertiary hospital

You may not qualify if:

  • Patients known to have obstructive sleep apnea.
  • Patients younger than 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ayman Hammoudeh

Amman, 11184, Jordan

Location

Istishari Hospital

Amman, 11888, Jordan

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 8, 2023

Study Start

October 15, 2023

Primary Completion

February 15, 2025

Study Completion

February 22, 2025

Last Updated

February 25, 2025

Record last verified: 2025-02

Locations